中文 | English
Return
Total: 2 , 1/1
Show Home Prev Next End page: GO
Author:(Hassan JUMAA)

1.Clinical and Safety Outcomes of Endovascular Therapy 6 to 24 Hours After Large Vessel Occlusion Ischemic Stroke With Tandem Lesions

Milagros GALECIO-CASTILLO ; Mudassir FAROOQUI ; Ameer E. HASSAN ; Mouhammad A. JUMAA ; Afshin A. DIVANI ; Marc RIBO ; Michael ABRAHAM ; Nils H. PETERSEN ; Johanna T. FIFI ; Waldo R. GUERRERO ; Amer M. MALIK ; James E. SIEGLER ; Thanh N. NGUYEN ; Sunil SHETH ; Albert J. YOO ; Guillermo LINARES ; Nazli JANJUA ; Darko QUISPE-OROZCO ; Wondwossen TEKLE ; Syed F. ZAIDI ; Sara Y. SABBAGH ; Marta OLIVÉ-GADEA ; Tiffany BARKLEY ; Reade De LEACY ; Kenyon W. SPRANKLE ; Mohamad ABDALKADER ; Sergio SALAZAR-MARIONI ; Jazba SOOMRO ; Weston GORDON ; Charoskhon TURABOVA ; Juan VIVANCO-SUAREZ ; Aaron RODRIGUEZ-CALIENES ; Maxim MOKIN ; Dileep R. YAVAGAL ; Tudor JOVIN ; Santiago ORTEGA-GUTIERREZ

Journal of Stroke 2023;25(3):378-387

2.An optimized derivative of an endogenous CXCR4 antagonist prevents atopic dermatitis and airway inflammation.

Mirja HARMS ; Monica M W HABIB ; Simona NEMSKA ; Antonella NICOLÒ ; Andrea GILG ; Nico PREISING ; Pandian SOKKAR ; Sara CARMIGNANI ; Martina RAASHOLM ; Gilbert WEIDINGER ; Gönül KIZILSAVAS ; Manfred WAGNER ; Ludger STÄNDKER ; Ashraf H ABADI ; Hassan JUMAA ; Frank KIRCHHOFF ; Nelly FROSSARD ; Elsa SANCHEZ-GARCIA ; Jan MÜNCH

Acta Pharmaceutica Sinica B 2021;11(9):2694-2708

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 2 , 1/1 Show Home Prev Next End page: GO